Example: Heart Attack

Clinical Trials Sponsored by Clarus Therapeutics, Inc.

Total 11 results

  • NCT01699178
    Completed
    Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
    Conditions: Male Hypogonadism
  • NCT00695110
    Completed
    Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
    Conditions: Hypogonadism
  • NCT00911586
    Completed
    Pharmacokinetic Study to Determine Time to Steady-state
    Conditions: Male Hypogonadism, Primary Hypogonadism, Secondary Hypogonadism
  • NCT00924612
    Completed
    Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
    Conditions: Male Hypogonadism
  • NCT03973840
    Completed
    Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
    Conditions: Hypogonadism, Male
  • NCT02697188
    Completed
    Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
    Conditions: Hypogonadism
  • NCT01403116
    Completed
    Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
    Conditions: Male Hypogonadism
  • NCT02921386
    Completed
    The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
    Conditions: Hypogonadism
  • NCT02670343
    Completed
    Phlebotomy Study of Testosterone Undecanoate
    Conditions: Hypogonadism
  • NCT02722278
    Completed
    A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
    Conditions: Hypogonadism
  • NCT01765179
    Completed
    Safety and Efficacy Trial of Testosterone Undecanoate
    Conditions: Male Hypogonadism

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations